Report Id: SNS/HC/1781 | June 2022 | Region: Global | 125 Pages
The Neurovascular Devices Market Size was valued at USD 2.65 billion in 2021, and expected to reach USD 4.02 billion by 2028, and grow at a CAGR of 6.1% over the forecast period 2022-2028.
Endovascular treatment advances account for a major portion of new developments in the neurovascular devices market. The method has been shown to be beneficial in the treatment of cerebral aneurysms. In the therapeutic setting, a variety of neurovascular devices with new designs and materials have been developed and employed. Numerous innovative solutions for treating intracranial aneurysms have broadened the landscape of the neurovascular devices market over the last decade. Endovascular gadgets with low total blockage rates at the start. The introduction of alternative materials, the most famous of which are biopolymers and specialist materials such as nitinol, has fueled recent evolution in the neurovascular devices market. Producers are putting new designs to the test, notably for treating cerebral aneurysms with a wide neck. The efficacy of neurovascular devices is being bolstered by advances in procedural procedures, which is expanding the possibilities.
Increasing field of endovascular therapeutic research has concentrated on innovative treatments for acute ischemic strokes in recent years. Regulators have been surprisingly active in changing the standards for new device approval. Growing public awareness of the morbidity of diseases like Parkinson's disease and Alzheimer's disease, as well as situations like traumatic brain injury (TBI), has led to a surge in research into neuro-interventional endovascular techniques. Healthcare providers are on the lookout for devices that are both safe and effective in treating different forms of cerebral aneurysms.
Demand for neurovascular devices grows as the patient pool grows.
Pharmaceutical and biotechnology companies are investing more in R&D.
Neurovascular treatments have progressed technologically.
Efforts by governments around the world to improve healthcare facilities
Negligibly intrusive careful strategies are turning out to be progressively famous.
Neurovascular Devices Have a High Price Tag
Neurovascular procedures and related goods have a high procedure cost.
Huge Demand for Minimally Invasive Processes to Create Opportunities
Emerging markets provide potential.
Growth is being hampered by a scarcity of competent neurosurgeons.
Regulations that are rigid
Treatments that are both effective and inexpensive are required.
IMPACT OF COVID-19
The COVID-19 epidemic has had a significant impact on the medical device sector, notably interventional neurology devices. In spite of the criticalness, the quantity of patient visits to clinics has diminished emphatically during the most recent a half year. During the COVID-19 plague, there is a great deal of variety in how neuro interventional techniques are taken care of. To avoid contact with COVID-19 patients and healthcare staff, patients are avoiding healthcare establishments. A variety of acute and critical illnesses, such as stroke, myocardial infarction, and various malignancies, have shown declining rates. As governments and authorities work to secure the resource availability for COVID-19 patients, the percutaneous neurology devices market is projected to be impacted. Supply chains have been affected by closed manufacturing facilities as a result of lockdowns, and clinical trial recruitment has been decreased, reducing the overall market's growth.
By Device Type:
neurovascular gadget market is portioned into cerebral angioplasty and stenting frameworks, cerebral embolization and aneurysm winding gadgets, and backing gadgets. Cerebral embolization and aneurysm snaking gadgets is additionally portioned into, stream redirection gadgets, embolic loops, and fluid embolic specialists. Cerebral angioplasty and stenting frameworks are additionally sectioned into embolic security frameworks and carotid corridor stents. Neurothrombectomy gadgets are additionally ordered into clump recovery gadgets, pull gadgets, and vascular catches.
In 2021, cerebral embolization and aneurysm curling gadgets ruled the neurovascular gadget market with the portion of 37.69%. Expanding pervasiveness of neurological circumstances like cerebrum aneurysm, stroke, arteriovenous abnormalities (AVMs), rising medical services consumption, and expanding R&D venture are not many elements contributing towards the market development.
By Therapeutic Application:
Due to reasons such as rising frequency of stroke, hypertension, and other neurological illnesses, the stroke category dominated the market with a CAGR of 6.1 percent. Strokes are the world's second greatest cause of death, accounting for over 140,000 deaths in the United States each year.
Increased government and non-governmental organisation (NGO) awareness campaigns around the world are helping to the segment's growth. For example, in 2018, the Stroke Alliance for Europe (SAFE), a non-profit organisation with members from 12 countries, joined Boehringer Ineglheim's (BI) Angel's Initiative to provide essential information to stroke victims. The introduction of technologically enhanced items is also propelling the industry forward.
Some of the major key players are as follows: Johnson and Johnson Services Inc., Penumbra, Inc., Microport Scientific Corporation, Stryker, Microvention Inc (Terumo Corporation), Codman Neuro (Integra Lifesciences), Medtronic, and other players.
By Device Type
Cerebral Embolization and Aneurysm Coiling Devices
Liquid Embolic Agents
Cerebral Angioplasty and Stenting Systems
Embolic Protection Devices
Carotid Artery Stents
Clot Retrieval Devices
By Therapeutic Application
Cerebral Artery Stenosis
Aneurysmal Subarachnoid Hemorrhage
Because of the large number of important companies functioning in the neurovascular devices market, North America accounted for a considerable portion of the market size and is likely to continue this trend. Johnson & Johnson, Stryker Corporation, Penumbra, Inc., Merit medical systems, Inc. are a portion of the significant ventures in the locale. As a result of the presence of significant players in the region, neurovascular devices are readily available. Other factors, such as the rise in the prevalence of neurovascular illnesses, are also driving the growth of the neurovascular devices market in the area. Furthermore, due to an increase in awareness about the use of neurovascular devices, Asia-Pacific is predicted to develop at the quickest rate.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2021||US$ 2.65 Billion|
|Market Size by 2028||US$ 4.02 Billion|
|CAGR||CAGR of 6.1% From 2022 to 2028|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Device Type (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices)
• By Therapeutic Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm, Others)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Johnson and Johnson Services Inc., Penumbra, Inc., Microport Scientific Corporation, Stryker, Microvention Inc (Terumo Corporation), Codman Neuro (Integra Lifesciences), Medtronic, and other players.|
|DRIVERS||• Demand for neurovascular devices grows as the patient pool grows.
• Pharmaceutical and biotechnology companies are investing more in R&D.
• Neurovascular treatments have progressed technologically.
|RESTRAINTS||• Neurovascular Devices Have a High Price Tag
• Neurovascular procedures and related goods have a high procedure cost.
Frequently Asked Questions (FAQ) :
Because of the large number of important companies functioning in the neurovascular devices market, North America accounted for a considerable portion of the market size and is likely to continue this trend.
Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm and others are the sub segments of Therapeutic Application.
Key drivers of the Neurovascular Devices Market is Neurovascular treatments have progressed technologically, Efforts by governments around the world to improve healthcare facilities
Endovascular treatment advances account for a major portion of new developments in the neurovascular devices market. The method has been shown to be beneficial in the treatment of cerebral aneurysms. In the therapeutic setting, a variety of neurovascular devices with new designs and materials have been developed and employed.
Neurovascular Devices Market Size was valued at USD 2.65 billion in 2021, and expected to reach USD 4.02 billion by 2028, and grow at a CAGR of 6.1% over the forecast period 2022-2028.
Table of Content
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of Ukraine ware
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Neurovascular Devices Market Segmentation, By Device Type
8.1 Cerebral Embolization and Aneurysm Coiling Devices
8.1.1 Embolic Coils
8.1.2 Liquid Embolic Agents
8.1.3 Flow Diverters
8.2 Cerebral Angioplasty and Stenting Systems
8.2.1 Embolic Protection Devices
8.2.2 Carotid Artery Stents
8.3 Neurothrombectomy Devices
8.3.1 Clot Retrieval Devices
8.3.2 Vascular Snares
8.3.3 Suction Devices
8.4 Support Devices
8.4.1 Micro Guidewires
9. Neurovascular Devices Market Segmentation, By Therapeutic Application
9.2 Cerebral Artery Stenosis
9.3 Cerebral Aneurysm
9.3.1 Aneurysmal Subarachnoid Hemorrhage
10. Regional Analysis
10.2 North America
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4.2 South Korea
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.3 South Africa
10.6 Latin America
10.6.3 Rest of Latin America
11 Company Profiles
11.1 Johnson and Johnson Services Inc.
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.3 Penumbra, Inc.
11.4 Microport Scientific Corporation
11.6 Microvention Inc (Terumo Corporation)
11.7 Codman Neuro (Integra Lifesciences)
12 Competitive Landscape
12.1 Competitive Benchmark
12.2 Market Share analysis
12.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.